Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Franklin India NSE Nifty 50 Index Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹174.16 |
| 26 Aug 2009 | ₹134.03 |
| 08 May 2011 | ₹158.35 |
| 17 Jan 2013 | ₹172.92 |
| 30 Sep 2014 | ₹228.52 |
| 11 Jun 2016 | ₹235.62 |
| 21 Feb 2018 | ₹298.76 |
| 04 Nov 2019 | ₹344.21 |
| 16 Jul 2021 | ₹458.02 |
| 28 Mar 2023 | ₹490.44 |
| 08 Dec 2024 | ₹720.04 |
| 20 Aug 2026 | ₹715.33 |
| Metric | Franklin Templeton · Regular NAV ₹196.61 Very High risk ★★★☆☆ | Category median Index Funds · 366 funds |
|---|---|---|
| -2.75% | +5.43% | |
| +8.48% | +8.41% | |
| +8.60% | +8.95% | |
| +11.06% | +11.28% | |
| +10.14% | +7.40% | |
| +7.00% | — | |
| +11.05% | +11.37% | |
| +10.90% | +13.00% | |
| +10.77% | +11.07% | |
| Risk | ||
| 13.15% | 13.88% | |
| 0.15 | 0.25 | |
| 0.21 | 0.35 | |
| -59.53% | -16.66% | |
| Nifty 50 | — | |
| +0.54% | +0.30% | |
| 0.99 | 1.00 | |
| 100.9% | 101.3% | |
| 97.5% | 98.8% | |
| 0.67% | 0.96% | |
| ₹732.67Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 0% | 35% | |
| Sandeep Manam · 4.8y | — | |
| 03 Apr 2006 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.